Bruker Corporation
BRKR
$36.28
-$1.46-3.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 113.10M | 304.90M | 352.10M | 401.60M | 427.20M |
| Total Depreciation and Amortization | 183.80M | 168.20M | 143.80M | 124.50M | 114.90M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 32.60M | -158.40M | -138.90M | -115.30M | -104.20M |
| Change in Net Operating Assets | -78.20M | -47.90M | -84.50M | -126.40M | -87.80M |
| Cash from Operations | 251.30M | 266.80M | 272.50M | 284.40M | 350.10M |
| Capital Expenditure | -115.30M | -110.10M | -104.40M | -103.30M | -106.90M |
| Sale of Property, Plant, and Equipment | 1.10M | 1.10M | 1.30M | 900.00K | 11.10M |
| Cash Acquisitions | -1.60B | -1.58B | -1.70B | -413.00M | -226.60M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43.50M | -43.50M | -17.40M | -6.60M | -3.60M |
| Cash from Investing | -1.76B | -1.73B | -1.82B | -522.00M | -326.00M |
| Total Debt Issued | 2.22B | 2.04B | 1.88B | 270.90M | 2.00M |
| Total Debt Repaid | -1.35B | -1.12B | -969.60M | -125.30M | -23.50M |
| Issuance of Common Stock | 411.80M | 413.30M | 415.30M | 12.20M | 9.50M |
| Repurchase of Common Stock | -2.80M | -53.20M | -129.90M | -129.90M | -152.30M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -30.20M | -29.90M | -29.70M | -29.30M | -29.40M |
| Other Financing Activities | -24.90M | -8.40M | -9.20M | -9.60M | 300.00K |
| Cash from Financing | 1.23B | 1.24B | 1.16B | -11.00M | -193.40M |
| Foreign Exchange rate Adjustments | -28.70M | 6.60M | -11.70M | -9.50M | 12.20M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -304.90M | -215.20M | -405.00M | -258.10M | -157.10M |